MOHCY yields 5.18% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, MOHCY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MOHCY + PFE for your $10,000?
Motor Oil (Hellas) Corinth Refineries S.A. engages in oil refining and oil products trading in Greece and internationally. It operates through four segments: Refining Activity, Fuels' Marketing Activity, Power & Gas, and Other. The company produces and sells liquid fuels, lubricants, and asphalt for transportation, industrial, and household use. It also markets and distributes a range of oil products, including gasoline, fuel oil, diesel, and lubricants through a retail network of approximately 796 stations under the SHELL name; retail service comprising 24 SHELL branded fuel sites; and operates 531 gas stations under AVIN brand name and 111 gas stations under CYCLON brand. In addition, the company engages in oil trading, storage agency, and services; collection and trading of used lubricants; research, exploration, and trading of crude oil; and marketing and distribution of liquefied petroleum gas, as well as operates aircraft fuel supply system and the storage facilities at the Athens International Airport at Spata of Attica. Further, it is involved in the purchase, sale, exploitation, and development of real estate properties; and provision of liquefied petroleum gas, facilities management services, and financial services, as well as systems of alternative management of lubricant wastes. The company was founded in 1970 and is headquartered in Marousi, Greece.
Full MOHCY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.